Jennifer S. Pascoe
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Investigating age and ethnicity as novel high-risk phenotypes in mucinous ovarian cancer: retrospective study in a multi-ethnic population.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 11, 2024
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).
Journal: Scientific reports
Published: February 03, 2023
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.
Journal: JAMA oncology
Published: December 22, 2022
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 15, 2022
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.
Journal: The Lancet. Oncology
Published: January 25, 2022
Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Published: January 15, 2020
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.
Journal: Science translational medicine
Published: December 05, 2019
Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy.
Journal: Archives of gynecology and obstetrics
Published: May 14, 2019
Temsirolimus for patients with metastatic renal cell carcinoma: outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center.
Journal: Drug design, development and therapy
Published: January 02, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026